# Goldenrod Therapeutics, Inc. — Form D

Goldenrod Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-06-03. The offering totals $6.5M, of which $3.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-06-03
- Form: D
- Accession: 0002127885-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $3.2M
- Remaining: $3.3M
- Minimum investment: $100K
- Investors: 2
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-586108

## Issuer

- Name: Goldenrod Therapeutics, Inc.
- CIK: 0002127885
- Entity type: Corporation
- Jurisdiction: TEXAS
- Address: 3900 ESSEX LANE, SUITE 575 Suite 575, HOUSTON, TX, 77027
- Phone: 713-966-5844

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Thomas Brenninkmeijer | Related Person | Houston, TX |
| Dev Chatterjee | Related Person | Houston, TX |
| Leo Linbeck III | Related Person | Houston, TX |
| Leo Linbeck IV | Related Person | Houston, TX |
| Atul Varadhachary | Related Person | Houston, TX |
| Mark Worscheh | Related Person | Houston, TX |

## More

- [CIK 2127885 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2127885&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002127885-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.